Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126802751 | 12680275 | 1 | I | 20100725 | 20121022 | 20160824 | 20160824 | EXP | GB-PFIZER INC-1465841 | PFIZER | 16.00 | YR | F | Y | 66.00000 | KG | 20160824 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126802751 | 12680275 | 1 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 60 MG, CYCLIC (60 MG, FREQ: 1 CYCLICAL; INTERVAL: 2) | U | UNK | 50467 | 60 | MG | ||||||
126802751 | 12680275 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, CYCLIC (2 MG, FREQ: 1 CYCLICAL; INTERVAL:1) | U | UNK | 71484 | 2 | MG | ||||||
126802751 | 12680275 | 3 | SS | ACTINOMYCIN D | DACTINOMYCIN | 1 | Intravenous (not otherwise specified) | 2 MG, CYCLIC (2 MG, FREQ: 1 CYCLICAL; INTERVAL: 1) | U | 0 | 2 | MG | |||||||
126802751 | 12680275 | 4 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 6 G, CYCLIC (6 G, FREQ: 1 CYCLICAL; INTERVAL: 2) | U | 0 | 6 | G | |||||||
126802751 | 12680275 | 5 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
126802751 | 12680275 | 6 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | 2.5 G, UNK | 0 | 2.5 | G | |||||||||
126802751 | 12680275 | 7 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 960 MG, UNK | 0 | 960 | MG | |||||||||
126802751 | 12680275 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 24 MG, UNK | 0 | 24 | MG | |||||||||
126802751 | 12680275 | 9 | C | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | 50 UG, UNK (50 UG, FREQ: 3 DAY; INTERVAL: 1) | 0 | 50 | UG | |||||||||
126802751 | 12680275 | 10 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
126802751 | 12680275 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | 1500 MG, UNK | 0 | 1500 | MG | |||||||||
126802751 | 12680275 | 12 | C | GRANISETRON | GRANISETRON | 1 | 1 MG, UNK | 0 | 1 | MG | |||||||||
126802751 | 12680275 | 13 | C | LACTULOSE. | LACTULOSE | 1 | 15 MG, UNK | 0 | 15 | MG | |||||||||
126802751 | 12680275 | 14 | C | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | 6 MG, UNK | 0 | 6 | MG | |||||||||
126802751 | 12680275 | 15 | C | MAGNESIUM ASPARTATE | MAGNESIUM ASPARTATE | 1 | 20 MMOL, UNK | 0 | 20 | MMOL | |||||||||
126802751 | 12680275 | 16 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
126802751 | 12680275 | 17 | C | NABILONE | NABILONE | 1 | 3 MG, UNK | 0 | 3 | MG | |||||||||
126802751 | 12680275 | 18 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
126802751 | 12680275 | 19 | C | ONDANSETRON | ONDANSETRON | 1 | 24 MG, UNK | 0 | 24 | MG | |||||||||
126802751 | 12680275 | 20 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 4 G, UNK | 0 | 4 | G | |||||||||
126802751 | 12680275 | 21 | C | PHOSPHATE SANDOZ | 2 | UNK | 0 | ||||||||||||
126802751 | 12680275 | 22 | C | SANDO K /00031402/ | 2 | 4 DF, UNK | 0 | 4 | DF | ||||||||||
126802751 | 12680275 | 23 | C | SANDOL P | 2 | TTX3 | 0 | ||||||||||||
126802751 | 12680275 | 24 | C | SANDOL P | 2 | TTX3 | 0 | ||||||||||||
126802751 | 12680275 | 25 | C | SENNA /00142201/ | SENNA LEAF | 1 | 15 MG, UNK | 0 | 15 | MG | |||||||||
126802751 | 12680275 | 26 | C | SEVREDOL | MORPHINE | 1 | 20 MG, AS NEEDED (20 MG, EVERY 4 HOURS, FREQ: AS NEEDED) | 0 | 20 | MG | |||||||||
126802751 | 12680275 | 27 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 18 G, UNK | 0 | 18 | G |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126802751 | 12680275 | 1 | Rhabdomyosarcoma |
126802751 | 12680275 | 2 | Rhabdomyosarcoma |
126802751 | 12680275 | 3 | Rhabdomyosarcoma |
126802751 | 12680275 | 4 | Rhabdomyosarcoma |
126802751 | 12680275 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126802751 | 12680275 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126802751 | 12680275 | Febrile neutropenia | |
126802751 | 12680275 | Presyncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126802751 | 12680275 | 1 | 20100618 | 0 | ||
126802751 | 12680275 | 2 | 20100618 | 0 | ||
126802751 | 12680275 | 3 | 20100618 | 0 | ||
126802751 | 12680275 | 4 | 20100618 | 0 | ||
126802751 | 12680275 | 5 | 20101015 | 0 | ||
126802751 | 12680275 | 6 | 20100716 | 0 | ||
126802751 | 12680275 | 7 | 20100621 | 0 | ||
126802751 | 12680275 | 8 | 20100713 | 20100930 | 0 | |
126802751 | 12680275 | 9 | 20100713 | 0 | ||
126802751 | 12680275 | 10 | 20100924 | 0 | ||
126802751 | 12680275 | 11 | 20100909 | 0 | ||
126802751 | 12680275 | 12 | 20100620 | 0 | ||
126802751 | 12680275 | 13 | 20100725 | 0 | ||
126802751 | 12680275 | 14 | 20100924 | 20100929 | 0 | |
126802751 | 12680275 | 15 | 20100612 | 0 | ||
126802751 | 12680275 | 16 | 20100614 | 0 | ||
126802751 | 12680275 | 17 | 20100714 | 0 | ||
126802751 | 12680275 | 18 | 20100713 | 0 | ||
126802751 | 12680275 | 19 | 20100722 | 0 | ||
126802751 | 12680275 | 20 | 20100909 | 0 | ||
126802751 | 12680275 | 21 | 20100717 | 0 | ||
126802751 | 12680275 | 22 | 20100724 | 0 | ||
126802751 | 12680275 | 23 | 20101103 | 0 | ||
126802751 | 12680275 | 24 | 20100717 | 0 | ||
126802751 | 12680275 | 25 | 20100621 | 0 | ||
126802751 | 12680275 | 26 | 20100617 | 0 | ||
126802751 | 12680275 | 27 | 20100722 | 0 |